Warning letter
Auro Pharmacies Inc: warning letter of Sep 24, 2018
FDA warning letter 565110 · San Francisco District Office
Key facts
| Reference number | 565110 |
|---|---|
| Company | Auro Pharmacies Inc |
| Subject | Auro Pharmacies Inc, Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Sep 24, 2018 |
| Posted date | Sep 24, 2018 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| CFR sections cited | 211.192, 201.115, 200.10(b), 211.42(c)(10)(iv), 211.94(c), 211.113(b), 211.165(a), 211.166(a), 211.167(a), 210.1(b) |
| Inspection city | La Habra |
| Inspection ZIP | 90631 |
| Inspection start date | Jun 13, 2017 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: